ITC’s numbers for Q3FY21 were on expected lines with cigarettes business reporting 92% recovery in net sales and EBIT, marginally ahead of estimates.
ITC Ltd
- ITC’s numbers for Q3FY21 were on expected lines with cigarettes business reporting 92% recovery in net sales and EBIT, marginally ahead of estimates.
- In 9MFY21, ITC introduced health soaps, disinfectant sprays, body wash, wipes and masks under Savlon brand. It remains to be seen how ITC capitalizes on this and scales up.
- For Q4FY21, we expect 9% yoy growth in cigarette volumes, 14% yoy growth in cigarette gross sales with 5% price-mix impact. We forecast 10% yoy growth in cigarette EBIT.
- In the FMCG portfolio for Q4FY21, we expect sequential demand trends to hold, with some moderation in health & hygiene portfolio and recovery in discretionary segment. We model 15.2%/70% yoy growth in FMCG revenue/EBIT.
- ITC offers a good combination of inexpensive valuations, healthy dividend yield and the promise of solid Long term growth in FMCG.
ITC Ltd: BUY
Dated: 19 th April 2021
CMP: Rs.208
Fair Value: Rs.265
Potential Upside: 27.4%
Market Cap: Rs.256,046 Cr
Time Frame: 12 months
Note: The above is a brief note on the company, based on the inputs of a KIE research report dated 12 th February 2021 & Strategy Preview Report dated 7 th April 2021, which is available on our website at: https://www.kotaksecurities.com/ksweb/ResearchCall/Fundamental . Disclaimer: http://bit.ly/2n5AxIE
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. Please refer the Risk Disclosure Document issued by SEBI and go through the Rights and Obligations and Do's and Dont's issued by Stock Exchanges and Depositories before trading on the Stock Exchanges .

OPEN YOUR ACCOUNT NOW !
